The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s small molecule API market report forecasts the small molecule API market size to grow to $246.18 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Small Molecule API Market Report 2023 – https://www.thebusinessresearchcompany.com/report/small-molecule-api-global-market-report

Small Molecule API Market Size Forecast
The global small molecule API market is expected to grow from $180.67 billion in 2022 to $193.62 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The small molecule API market is expected to grow to $246.18 billion in 2027 at a CAGR of 6.2%.

North America held the largest small molecule API market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Small Molecule API Market Driver ­– Growth In Demand For Small-Molecule Drugs
According to the National Center for Biotechnology Information (NCBI), in 2021, 75% of the drugs accepted by the Food and Drug Administration (FDA) were small molecules, with the dominant therapeutic area being oncology. Over 50% of these approvals were from small and mid-sized companies, which require support from CDMOs for the commercialization of products that contribute to the growth of CDMOs. Therefore, the growing demand for small-molecule drugs is driving the growth of the small-molecule API market.

Request for A Sample Of The Global Small Molecule API Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8236&type=smp

Key Small Molecule API Market Trend – Strategic Partnership
Many companies operating in the small-molecule API market are undergoing partnerships to strengthen their position in the small-molecule API market and advance the development of various drugs and therapies. For instance, in December 2020, a US-based pharmaceutical and biotechnology company Pfizer Inc. partnered with a US-based machine learning medicinal chemistry company, PostEra. This partnership aims to accelerate small molecule drug discovery by developing a platform technology based on generative chemistry. Further, in January 2020, a US-based pharmaceutical company, Merck partnered with Japanese pharmaceutical company, Taiho Pharmaceutical Co., Ltd. This partnership aims to expand its focus on small-molecule inhibitors for cancer research.

Small Molecule API Market Segment
1) By Type: Synthetic, Biotech
2) By Manufacturer: In-House, Outsourced
3) By Application: Cardiology, Oncology, CNS And Neurology, Orthopaedic, Endocrinology, Other Applications

Small Molecule API Market Major Players and Strategies
Major players in the small molecule API market are Merck & Co., Inc., AbbVie, Inc., Bristol-Myers Squibb Company, Albemarle Corporation, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Aurobindo Pharma, Cambrex Corporation, Lonza, Siegfried AG, AstraZeneca, Hoffmann-La Roche Ltd., AND Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

In March 2022, GHO Capital, a European specialist investor in healthcare companies, acquired a majority stake in Sterling Pharma Solutions. With this acquisition, GHO Capital will facilitate the extensive sectoral pharmaceutical expertise in Europe and expand its market share in the U.S. Sterling Pharma Solutions is a US-based manufacturer of active pharmaceutical ingredients (APIs).

The Small Molecule API Global Market Report 2023 covers regional data on small molecule API market size, small molecule API market trends and drivers, opportunities, strategies, and small molecule API market competitor analysis. The countries covered in the small molecule API market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Small molecules API (active pharmaceutical ingredient) refers to organic components that have a low molecular weight of less than 1 nm and are typically made up of 20–100 atoms. These are active ingredients found in a wide range of biological and pharmaceutical procedures. Small molecules can be used as research tools to investigate biological function and to help develop new therapeutic agents. The small molecule API are used in pharmaceuticals and biological procedures.

View More Reports Related To The Small Molecule API Market –
Small Electrical Appliance Global Market Report 2023
Molecular Diagnostics Devices And Equipment Global Market Report 2023
API Management Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: